Myths vs facts: tTG IgA and longevity

The tTG-IgA antibody test (tissue transglutaminase IgA) is a well-established biomarker for celiac disease, not longevity. A positive result indicates an autoimmune reaction to gluten, which, if untreated, can lead to nutrient malabsorption, chronic inflammation, and increased risk of osteoporosis, lymphoma, and other complications – factors that may indirectly affect lifespan. However, there is no scientific evidence that tTG-IgA levels directly predict longevity. Myths often arise from conflating celiac diagnostics with general health optimization. Fact: A positive tTG-IgA test requires medical follow-up and a gluten-free diet to prevent long-term damage. In healthy individuals without celiac disease, the marker has no relevance for life expectancy. The evidence for its diagnostic utility is strong (human-strong), but for a direct longevity link it is unclear. Consumers should be wary of marketing claims that present tTG-IgA as a 'longevity marker.' This test belongs in a clinical context, not in lifestyle panels.